Ng, W. H., Fu, S., Chan, K., Chung, K. Y., Hui, T. Y. C., Zhao, Q., Leung, K. T. (2025). Fc engineering of CD9 antibodies overcomes platelet toxicity and preserves superior potency against refractory acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-6858